Skip to main content

Kaitlin Kestenberg

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Kaitlin Kestenberg

Kaitlin Kestenberg is recorded as COO at Adma Biologics, Inc. (ADMA). Adma Biologics, Inc. reported in an 8-K filed April 2, 2024 that Kaitlin Kestenberg was appointed Chief Operating Officer and Senior Vice President, Compliance, effective April 1, 2024. The proxy statement of Adma Biologics, Inc. reports total compensation of $3,488,647 for Kaitlin Kestenberg in fiscal 2025, including a base salary of $575,000. Disclosed compensation is on record for 4 fiscal years.

“Effective April 1, 2024 (the “Effective Date”), Kaitlin Kestenberg, former Senior Vice President, Compliance & Project Operations of ADMA Biologics, Inc. (the “Company”), was promoted to Chief Operating Officer and Senior Vice President, Compliance of the Company (the “Promotion”).”
Adma Biologics, Inc. Form 8-K, filed April 2, 2024 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Adma Biologics, Inc.

Other people whose current roles at this company are on record from its filings.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Adma Biologics, Inc. (ADMA) $575,000 $3,488,647
2024 Adma Biologics, Inc. (ADMA) $433,137 $3,340,020
2023 Adma Biologics, Inc. (ADMA) — —
2022 Adma Biologics, Inc. (ADMA) — —

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.